Equity Analysis

Quarterly Results

    Gennex Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    531739
    INE509C01026
    7.2561683
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    34.59
    464.22
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0.59
    1
    0
     
Quarters
(RupeeIcon Cr)
ParticularsJun 2024Mar 2024Dec 2023
Gross Sales21.3321.3317.08
Other Operating Income0.000.000.00
Other Income 2.461.972.24
Total Income23.7923.3019.32
Total Expenditure 18.4118.2415.64
PBIDT5.385.063.68
Interest 0.290.250.32
PBDT5.094.813.36
Depreciation0.170.200.20
Tax0.750.770.52
Fringe Benefit Tax0.000.000.00
Deferred Tax0.00-0.090.00
Reported Profit After Tax4.173.932.64
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item4.173.932.64
EPS (Unit Curr.)0.180.240.15
EPS (Adj) (Unit Curr.)0.180.240.15
Calculated EPS (Unit Curr.)0.180.170.15
Calculated EPS (Adj) (Unit Curr.)0.180.170.15
Calculated EPS (Ann.) (Unit Curr.)0.730.690.59
Calculated EPS (Adj) (Ann.) (Unit Curr.)0.730.690.59
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity22.7422.7417.74
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)25.2223.7221.55
PBDTM(%)23.8622.5519.67
PATM(%)19.5518.4215.46
Dividend Per Share(Rs)0.000.000.00
Diluted EPS0.180.220.15